Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
Open Access
- 23 January 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (1) , e54610
Abstract
Multicentric Castleman Disease is largely driven by increased signaling in the pathway for the plasma cell growth factor interleukin-6. We hypothesized that interleukin-6/interleukin-6 receptor/gp130 polymorphisms contribute to increased interleukin-6 and/or other components of the interleukin-6 signaling pathway in HIV-negative Castleman Disease patients. The study group was composed of 58 patients and 50 healthy donors of a similar racial/ethnic profile. Of seven polymorphisms chosen for analysis, we observed an increased frequency between patients and controls of the minor allele of interleukin-6 receptor polymorphism rs4537545, which is in linkage disequilibrium with interleukin-6 receptor polymorphism rs2228145. Further, individuals possessing at least one copy of the minor allele of either polymorphism expressed higher levels of soluble interleukin-6 receptor. These elevated interleukin-6 receptor levels may contribute to increased interleukin-6 activity through the trans-signaling pathway. These data suggest that interleukin-6 receptor polymorphism may be a contributing factor in Castleman Disease, and further research is warranted.Keywords
This publication has 26 references indexed in Scilit:
- An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplificationBlood, 2012
- Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:rs1800795(Promoter) andrs8192284(Receptor)Clinical Cancer Research, 2009
- IL6 genotypes and colon and rectal cancerCancer Causes & Control, 2007
- A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effectsGenes & Immunity, 2007
- Admixture Mapping of an Allele Affecting Interleukin 6 Soluble Receptor and Interleukin 6 LevelsThe American Journal of Human Genetics, 2007
- Interleukin-6-Related Genotypes, Body Mass Index, and Risk of Multiple Myeloma and PlasmacytomaCancer Epidemiology, Biomarkers & Prevention, 2006
- Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptorRheumatology, 2006
- Interleukin-6 and its receptor: from bench to bedsideMedical Microbiology and Immunology, 2006
- Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influencedGenes & Immunity, 2004
- Blased Tests of Association: Comparisons of Allele Frequencies when Departing from Hardy-Weinberg ProportionsAmerican Journal of Epidemiology, 1999